arginine has been researched along with fulvestrant in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chen, Z; German, Z; Kirsch, EA; Shaul, PW; Sherman, TS; Yuhanna, IS | 1 |
| Nishio, I; Tsuda, K | 1 |
| Bowers, CY; Keenan, DM; Veldhuis, JD | 1 |
| Büssemaker, E; Hagedorn, C; Hausberg, M; Hillebrand, U; Kliche, K; Lang, D; Oberleithner, H; Pavenstädt, H; Reuter, S; Stock, CM; Telgmann, RG | 1 |
| Bernhardt, G; Buschauer, A; Keller, M; Lopuch, M; Memminger, M; Pop, N; von Angerer, E | 1 |
| Bowers, CY; Erickson, D; Miles, JC; Veldhuis, JD; Wigham, JR; Yang, RJ | 1 |
1 review(s) available for arginine and fulvestrant
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for arginine and fulvestrant
| Article | Year |
|---|---|
Peripheral estrogen receptor-alpha selectively modulates the waveform of GH secretory bursts in healthy women.
Topics: Administration, Cutaneous; Aged; Arginine; Double-Blind Method; Drug Administration Schedule; Estradiol; Estrogen Receptor alpha; Fulvestrant; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Middle Aged; Oligopeptides; Postmenopause; Somatostatin; Time Factors | 2007 |
Estrogen-like potentiation of ghrelin-stimulated GH secretion by fulvestrant, a putatively selective ER antagonist, in postmenopausal women.
Topics: Aged; Aged, 80 and over; Arginine; Cohort Studies; Double-Blind Method; Drug Synergism; Estradiol; Estrogen Antagonists; Estrogens; Female; Fulvestrant; Ghrelin; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Middle Aged; Postmenopause; Prospective Studies | 2014 |
4 other study(ies) available for arginine and fulvestrant
| Article | Year |
|---|---|
Estrogen acutely stimulates endothelial nitric oxide synthase in H441 human airway epithelial cells.
Topics: Animals; Arginine; Bronchi; Calcimycin; Cell Line; Dactinomycin; Enzyme Activation; Epithelial Cells; Estradiol; Estrogen Receptor alpha; Female; Fulvestrant; Humans; Kinetics; Menstruation; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; Sheep; Uterus | 1999 |
A selective estrogen receptor modulator, tamoxifen, and membrane fluidity of erythrocytes in normotensive and hypertensive postmenopausal women: an electron paramagnetic resonance investigation.
Topics: Aged; Analysis of Variance; Arginine; Cyclic GMP; Dose-Response Relationship, Drug; Drug Synergism; Electron Spin Resonance Spectroscopy; Enzyme Inhibitors; Erythrocyte Membrane; Erythrocytes; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Hypertension; Membrane Fluidity; NG-Nitroarginine Methyl Ester; Nitric Oxide Donors; Nitric Oxide Synthase; Postmenopause; S-Nitroso-N-Acetylpenicillamine; Selective Estrogen Receptor Modulators; Tamoxifen | 2005 |
Nebivolol decreases endothelial cell stiffness via the estrogen receptor beta: a nano-imaging study.
Topics: Adenocarcinoma; Adrenergic beta-Antagonists; Antihypertensive Agents; Arginine; Benzopyrans; Breast Neoplasms; Cell Line; Cell Line, Tumor; Cell Size; Dose-Response Relationship, Drug; Drug Combinations; Elasticity; Endothelial Cells; Estradiol; Estrogen Antagonists; Estrogen Receptor beta; Estrogen Receptor Modulators; Estrogens; Ethanolamines; Female; Fulvestrant; Genes, Reporter; Humans; Metoprolol; Nanotechnology; Nebivolol; Nitric Oxide; Nitrites; Tamoxifen; Time Factors; Transfection | 2009 |
The neuropeptide y y(1) receptor: a diagnostic marker? Expression in mcf-7 breast cancer cells is down-regulated by antiestrogens in vitro and in xenografts.
Topics: Animals; Arginine; Breast Neoplasms; Calcium; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Estradiol; Estrogen Receptor Modulators; Female; Fulvestrant; Humans; Mice; Mice, Nude; Neuropeptide Y; Receptors, Estrogen; Receptors, Neuropeptide Y; Tamoxifen | 2012 |